Jack R. Bennink - Concepedia

Author

Jack R. Bennink

National Institute of Allergy and Infectious Diseases

Also Known As

J Bennink, J R Bennink, J. Bennink, J. R. Bennink, J.R. Bennink, JACK R. BENNINK, Jack Bennink, Jack R Bennink, Jack R. Bennink, Jack R. Bennink

245

Publications

25.5K

Citations

H-Index

127

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases National Institutes of Health The Wistar Institute

About

Jack R. Bennink is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	68	122	17K
2	Natural Sciences	30	32	4.8K
3	Allergy	21	21	2.3K
4	Biochemistry	16	17	3.5K
5	Public Health	1	1	19

Jack R. Bennink

171

Publications

22.6K

Citations

H-Index

Page 1

	Year	Citations
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes Ulrich S. Schubert, Luis C. Antón, James S. Gibbs, Nature Protein ChemistryBiochemistryProtein FoldingMedicineNatural Sciences	2000	1.5K
A novel influenza A virus mitochondrial protein that induces cell death Weisan Chen, Paul A. Calvo, Daniela Malide, Nature Medicine Mitochondrial FunctionPathogenesisViral PathogenesisCell DeathVirology	2001	1K
CD1 Recognition by Mouse NK1 <sup>+</sup> T Lymphocytes Albert Bendelac, Olivier Lantz, Mary E. Quimby, Science HistocompatibilityLymphocyte DevelopmentT-regulatory CellHla ImmunogeneticsImmunology	1995	898
Localization, Quantitation, and In Situ Detection of Specific Peptide–MHC Class I Complexes Using a Monoclonal Antibody Angel Porgador, Jonathan W. Yewdell, Yuping Deng, Immunity MedicineBioanalysisImmunologyMolecular BiologySpecific Peptide–mhc Class	1997	673
Identification of human cancers deficient in antigen processing. Nicholas P. Restifo, Yutaka Kawakami, Jonathan W. Yewdell, The Journal of Experimental Medicine Tumor BiologyCancer ImmunosurveillanceMhc-encoded ProteasomeMhc ClassImmunology	1993	626
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. J W Yewdell, Jack R. Bennink, Geoffrey L. Smith, Proceedings of the National Academy of Sciences VaccinationViral ReplicationSystems BiologyMajor Target AntigenViral Pathogenesis	1985	521
Quantitating Protein Synthesis, Degradation, and Endogenous Antigen Processing Michael F. Princiotta, Diana Finzi, Shu‐Bing Qian, Immunity BiochemistryBiotechnologyImmunochemistryEndogenous Antigen ProcessingProtein Degradation	2003	520
Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? Jonathan W. Yewdell, Luis C. Antón, Jack R. Bennink The Journal of Immunology	1996	449
Expression of the 1918 Influenza A Virus PB1-F2 Enhances the Pathogenesis of Viral and Secondary Bacterial Pneumonia Julie McAuley, Felicita Hornung, Kelli L. Boyd, Cell Host & Microbe PathogenesisViral PathogenesisSecondary Bacterial PneumoniaRespiratory InfectionVirology	2007	395
Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol Sebastian Joyce, Amina S. Woods, Jonathan W. Yewdell, Science	1998	393

Page 1